Page last updated: 2024-08-25

nipradilol and Left Ventricular Dysfunction

nipradilol has been researched along with Left Ventricular Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, M; Sonoki, H; Takeshita, A1
Izutani, S; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M1

Other Studies

2 other study(ies) available for nipradilol and Left Ventricular Dysfunction

ArticleYear
Chronic therapy with nipradilol, a beta-adrenergic blocker, attenuated left ventricular remodeling following myocardial infarction in rats.
    Japanese journal of pharmacology, 1997, Volume: 74, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Female; Heart Rate; Myocardial Infarction; Propanolamines; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Pressure

1997
Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Biomarkers; Collagen Type I; Collagen Type III; Disease Models, Animal; Echocardiography, Doppler; Myocardial Infarction; Natriuretic Peptide, Brain; Propanolamines; Rats; Rats, Wistar; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling

2002